« Back
Home /
5,6-Dichlorobenzimidazole 1-beta-D-ribofuranoside

5,6-Dichlorobenzimidazole 1-beta-D-ribofuranoside

Item no.	CAPS-C02264-25mg
Manufacturer	Capsid Biotechnology
CASRN	53-85-0
Amount	25 mg
Quantity options	25 mg 5 mg
Category	Reagents & Chemicals Building Blocks & Intermediates Nucleosides & Nucleotides
Type	Chemicals
Specific against	other
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	DRB
Available
Storage Conditions	3 years -20°C powder
Small Target	Casein Kinase
Big Target	Cell Cycle
Information	5, 6-Dichlorobenzimidazole riboside(DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II and CDKs. It trigger p53-dependent apoptosis of human colon adenocarcinoma cells without inducing genotoxic stress to healthy cells.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question